300676 华大基因
2025/03 - 三个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(397,094)95,723408,768130,8832,476,132
投资活动产生之现金流量净额(221,580)(314,416)(1,750,741)(580,074)(2,292,050)
筹资活动产生之现金流量净额549,271(683,152)(266,882)(1,194,537)1,037,307
汇率变动对现金及现金等价物的影响1,14045,12132,822279,379(139,909)
现金及现金等价物净增加/(减少)(68,263)(856,724)(1,576,033)(1,364,349)1,081,480
期初现金及现金等价物余额2,698,4173,555,1415,131,1746,495,5235,410,064
期末现金及现金等价物余额2,630,1542,698,4173,555,1415,131,1746,491,544